Complete Filing Data
Camp4 Therapeutics Corp reported Stockholders Equity of $47.70 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Camp4 Therapeutics Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue * | $3.5M | $652.0K | $350.0K |
| Net Income Loss | -$80.4M | -$51.8M | -$49.3M |
| Research And Development Expense | $38.2M | $38.8M | $40.6M |
| Operating Income Loss | -$52.6M | -$53.1M | -$51.9M |
| Operating Expenses | $56.1M | $53.7M | $52.2M |
| Nonoperating Income Expense | -$27.8M | $1.3M | $2.6M |
| General And Administrative Expense | $17.4M | $14.9M | $11.6M |
| Comprehensive Income Net Of Tax | -$80.4M | -$51.8M | -$49.3M |
| Other Nonoperating Income Expense | |||
| Other Nonoperating Expense | $192.0K | $33.0K | $220.0K |
| Operating Lease Impairment Loss | $494.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $795.0K | $1.5M | $858.0K | $0.00 | $0.00 | $0.00 | $350.0K | ||
| Net Income Loss | -$15.1M | -$12.6M | -$12.4M | -$13.5M | -$12.6M | -$12.5M | -$11.7M | -$12.1M | -$12.5M |
| Research And Development Expense | $9.4M | $10.3M | $10.1M | $9.7M | $9.4M | $9.7M | $9.8M | ||
| Operating Income Loss | -$13.7M | -$13.0M | -$13.1M | -$13.5M | -$12.7M | -$12.9M | -$12.3M | ||
| Operating Expenses | $14.4M | $14.5M | $14.0M | $13.5M | $12.7M | $12.9M | $12.7M | ||
| Nonoperating Income Expense | -$1.4M | $441.0K | $667.0K | $32.0K | $86.0K | $423.0K | $642.0K | ||
| General And Administrative Expense | $4.6M | $4.2M | $3.8M | $3.8M | $3.3M | $3.1M | $2.9M | ||
| Comprehensive Income Net Of Tax | -$15.1M | -$12.6M | -$12.4M | -$13.5M | -$12.6M | -$12.5M | -$11.7M | ||
| Other Nonoperating Income Expense | -$71.0K | -$12.0K | $79.0K | -$62.0K | -$145.0K | $28.0K | |||
| Other Nonoperating Expense | $62.0K | $47.0K | |||||||
| Operating Lease Impairment Loss | $494.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $47.7M | $63.1M | -$123.7M | -$77.5M |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $162.1M | $162.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $111.8M | $65.7M | $40.0M | $84.5M |
| Restricted Cash Noncurrent | $894.0K | $1.6M | $1.6M | |
| Cash And Cash Equivalents At Carrying Value | $109.5M | $64.0M | $38.4M | |
| Retained Earnings Accumulated Deficit | -$292.2M | -$211.8M | -$160.0M | |
| Principal Payments On Financing Obligations Failed Sale Leaseback Transaction | $97.0K | $460.0K | $268.0K | |
| Prepaid Expense And Other Assets Current | $3.2M | $2.3M | $1.6M | |
| Operating Lease Right Of Use Asset | $397.0K | $6.0M | $7.8M | |
| Operating Lease Liability Noncurrent | $1.7M | $5.5M | $8.5M | |
| Operating Lease Liability Current | $286.0K | $3.0M | $2.7M | |
| Liabilities Current | $15.5M | $9.6M | $7.8M | |
| Liabilities And Stockholders Equity | $117.8M | $78.3M | $54.9M | |
| Liabilities | $70.1M | $15.2M | $16.5M | |
| Finance Lease Principal Payments | $111.0K | $364.0K | $322.0K | |
| Common Stock Value | $6.0K | $2.0K | $1.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $46.1M | $25.7M | -$44.5M | |
| Assets Current | $114.1M | $66.4M | $40.0M | |
| Assets | $117.8M | $78.3M | $54.9M | |
| Accrued Liabilities Current | $5.6M | $4.8M | $3.3M | |
| Accounts Payable Current | $182.0K | $1.2M | $1.0M | |
| Other Liabilities Noncurrent | $29.0K | $72.0K | $2.0K | |
| Finance Liability Current | $405.0K | |||
| Finance Lease Right Of Use Asset | $748.0K | |||
| Finance Lease Liability Noncurrent | $148.0K | |||
| Finance Lease Liability Current | $354.0K | |||
| Contract With Customer Liability Current | $9.4M | $385.0K | $0.00 | |
| Property Plant And Equipment Net | $4.8M | |||
| Operating Lease Right Of Use Asset Amortization Expense | $1.9M | $1.7M | ||
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | $0.00 | $504.0K | ||
| Finance Lease Right Of Use Asset Converted To Fixed Asset | $290.0K | $127.0K | $0.00 | |
| Temporary Equity Liquidation Preference | $0.00 | $162.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $58.7M | $40.0M | $51.6M | -$159.0M | -$147.1M | -$135.3M | -$111.6M | -$100.6M | -$89.3M | |
| Temporary Equity Carrying Amount Attributable To Parent | $162.1M | $162.1M | $162.1M | $162.1M | $162.1M | $162.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $76.9M | $40.7M | $50.9M | $4.2M | $14.2M | $28.6M | $52.1M | |||
| Restricted Cash Noncurrent | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | |||||
| Cash And Cash Equivalents At Carrying Value | $75.3M | $39.1M | $49.3M | $2.5M | $50.5M | |||||
| Retained Earnings Accumulated Deficit | -$251.9M | -$236.8M | -$224.2M | -$198.5M | ||||||
| Principal Payments On Financing Obligations Failed Sale Leaseback Transaction | $115.0K | $115.0K | ||||||||
| Prepaid Expense And Other Assets Current | $2.5M | $2.0M | $2.4M | $2.0M | ||||||
| Operating Lease Right Of Use Asset | $4.1M | $5.1M | $5.5M | $6.5M | ||||||
| Operating Lease Liability Noncurrent | $3.0M | $3.9M | $4.7M | $6.3M | ||||||
| Operating Lease Liability Current | $3.2M | $3.1M | $3.1M | $2.9M | ||||||
| Liabilities Current | $7.9M | $7.3M | $6.4M | $11.8M | ||||||
| Liabilities And Stockholders Equity | $86.4M | $51.3M | $62.8M | $21.4M | ||||||
| Liabilities | $27.7M | $11.3M | $11.2M | $18.2M | ||||||
| Finance Lease Principal Payments | $36.0K | $89.0K | ||||||||
| Common Stock Value | $5.0K | $2.0K | $2.0K | $2.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$14.7M | -$11.4M | ||||||||
| Assets Current | $77.7M | $41.1M | $51.7M | $5.5M | ||||||
| Assets | $86.4M | $51.3M | $62.8M | $21.4M | ||||||
| Accrued Liabilities Current | $4.1M | $2.9M | $1.8M | $3.7M | ||||||
| Accounts Payable Current | $585.0K | $1.2M | $1.4M | $3.9M | ||||||
| Other Liabilities Noncurrent | $2.0K | $2.0K | $2.0K | |||||||
| Finance Liability Current | $0.00 | $97.0K | $92.0K | $85.0K | $190.0K | |||||
| Finance Lease Right Of Use Asset | $90.0K | $97.0K | $331.0K | $427.0K | $602.0K | |||||
| Finance Lease Liability Noncurrent | $47.0K | $59.0K | $58.0K | $70.0K | $87.0K | |||||
| Finance Lease Liability Current | $27.0K | $26.0K | $43.0K | $91.0K | $170.0K | |||||
| Contract With Customer Liability Current | $0.00 | $0.00 | $0.00 | |||||||
| Property Plant And Equipment Net | $2.9M | $3.4M | $3.6M | $3.9M | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $475.0K | $403.0K | ||||||||
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | $70.0K | $0.00 | ||||||||
| Finance Lease Right Of Use Asset Converted To Fixed Asset | ||||||||||
| Temporary Equity Liquidation Preference | $162.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $4.0M | $4.0M | $2.9M |
| Payments To Acquire Property Plant And Equipment | $279.0K | $441.0K | $678.0K |
| Net Cash Provided By Used In Operating Activities | -$29.6M | -$45.6M | -$44.2M |
| Net Cash Provided By Used In Investing Activities | -$243.0K | -$441.0K | -$678.0K |
| Net Cash Provided By Used In Financing Activities | $75.9M | $71.7M | $301.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $888.0K | $711.0K | $420.0K |
| Increase Decrease In Operating Lease Assets Liabilities | $3.0M | $2.7M | -$402.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $805.0K | $1.5M | -$136.0K |
| Increase Decrease In Accounts Payable | -$1.0M | $168.0K | -$1.1M |
| Depreciation Depletion And Amortization | $1.6M | $1.7M | $1.7M |
| Proceeds From Issuance Of Common Stock | $57.5M | $76.4M | $0.00 |
| Increase Decrease In Contract With Customer Liability | $17.1M | $385.0K | $0.00 |
| Proceeds From Financing Obligations Failed Sale Leaseback Transaction | $51.0K | $113.0K | $706.0K |
| Payments Of Debt Issuance Costs | $0.00 | $4.0M | |
| Payments Of Stock Issuance Costs | $4.0M | $5.7M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q2 2023 |
|---|---|---|---|
| Share Based Compensation | $861.0K | $856.0K | |
| Payments To Acquire Property Plant And Equipment | $279.0K | $15.0K | |
| Net Cash Provided By Used In Operating Activities | -$14.3M | -$11.1M | |
| Net Cash Provided By Used In Investing Activities | -$279.0K | -$15.0K | |
| Net Cash Provided By Used In Financing Activities | -$151.0K | -$202.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $7.0K | $1.2M | |
| Increase Decrease In Operating Lease Assets Liabilities | $718.0K | $648.0K | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.8M | $448.0K | |
| Increase Decrease In Accounts Payable | $175.0K | $985.0K | |
| Depreciation Depletion And Amortization | $421.0K | $436.0K | |
| Proceeds From Issuance Of Common Stock | $0.00 | $2.0K | |
| Increase Decrease In Contract With Customer Liability | -$385.0K | $0.00 | |
| Proceeds From Financing Obligations Failed Sale Leaseback Transaction | $700.0K | ||
| Payments Of Debt Issuance Costs | |||
| Payments Of Stock Issuance Costs |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 130.6M | 130.6M |
| Weighted Average Number Of Shares Outstanding Basic | 30.4M | 4.7M | 395.0K | |
| Weighted Average Number Of Diluted Shares Outstanding | 30.4M | 4.7M | 395.0K | |
| Earnings Per Share Diluted | $-2.65 | $-11.04 | $-124.80 | |
| Earnings Per Share Basic | $-2.65 | $-11.04 | $-124.80 | |
| Common Stock Shares Authorized | 175.0M | 175.0M | 210.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 51.9M | 20.1M | 460.7K | |
| Common Stock Shares Issued | 51.9M | 20.2M | 1.0M | |
| Temporary Equity Shares Issued | 0.00 | 130.6M | ||
| Temporary Equity Shares Authorized | 25.0M | 149.7M | ||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 130.6M | 130.6M | 130.6M | 130.6M | 130.6M | 130.6M | |||
| Weighted Average Number Of Shares Outstanding Basic | 27.3M | 20.2M | 20.2M | 557.4K | 483.6K | 468.7K | 400.4K | ||
| Weighted Average Number Of Diluted Shares Outstanding | 27.3M | 20.2M | 20.2M | 557.4K | 483.6K | 468.7K | 400.4K | ||
| Earnings Per Share Diluted | $-0.55 | $-0.62 | $-0.62 | $-24.19 | $-26.00 | $-26.57 | $-29.21 | ||
| Earnings Per Share Basic | $-0.55 | $-0.62 | $-0.62 | $-24.19 | $-26.00 | $-26.57 | $-29.21 | ||
| Common Stock Shares Authorized | 175.0M | 175.0M | 175.0M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Shares Outstanding | 46.9M | 20.2M | 20.2M | 1.0M | |||||
| Common Stock Shares Issued | 46.9M | 20.2M | 20.2M | 1.0M | |||||
| Temporary Equity Shares Issued | 130.6M | ||||||||
| Temporary Equity Shares Authorized | 149.7M | ||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.0M | $4.0M | $2.9M |
| Investment Income Interest | $2.2M | $1.3M | $2.8M |
| Stock Issued During Period Value New Issues | $57.3M | $72.4M | $185.0K |
| Paid In Kind Interest | $16.0K | $83.0K | $92.0K |
| Additional Paid In Capital | $339.9M | $274.9M | $36.2M |
| Capital Expenditures Incurred But Not Yet Paid | $203.0K | $0.00 | $12.0K |
| Gain Loss On Derivative Instruments Net Pretax | -$29.8M | $0.00 | |
| Stock Issued During Period Value Stock Options Exercised | $51.0K | $113.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $984.0K | $1.0M | $861.0K | $1.6M | $786.0K | $856.0K | $722.0K | $786.0K | $763.0K |
| Investment Income Interest | $423.0K | $453.0K | $588.0K | $94.0K | $231.0K | $395.0K | $689.0K | ||
| Stock Issued During Period Value New Issues | $29.2M | $31.0K | $0.00 | $2.0K | $1.0K | $4.0K | $7.0K | ||
| Paid In Kind Interest | $111.0K | $27.0K | |||||||
| Additional Paid In Capital | $310.5M | $276.8M | $275.8M | $39.5M | |||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $151.0K | |||||||
| Gain Loss On Derivative Instruments Net Pretax | -$1.8M | $0.00 | |||||||
| Stock Issued During Period Value Stock Options Exercised | $3.0K | $31.0K | $2.0K |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.